These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26257832)

  • 21. The search for the "next" euphoric non-fentanil novel synthetic opioids on the illicit drugs market: current status and horizon scanning.
    Sharma KK; Hales TG; Rao VJ; NicDaeid N; McKenzie C
    Forensic Toxicol; 2019; 37(1):1-16. PubMed ID: 30636980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal intoxications associated with the designer opioid AH-7921.
    Kronstrand R; Thelander G; Lindstedt D; Roman M; Kugelberg FC
    J Anal Toxicol; 2014 Oct; 38(8):599-604. PubMed ID: 25217553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
    Bäckberg M; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two fatalities associated with synthetic opioids: AH-7921 and MT-45.
    Fels H; Krueger J; Sachs H; Musshoff F; Graw M; Roider G; Stoever A
    Forensic Sci Int; 2017 Aug; 277():e30-e35. PubMed ID: 28506719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.
    Evans-Brown M; Sedefov R
    Handb Exp Pharmacol; 2018; 252():3-49. PubMed ID: 30194542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychoactive substances in natural and unnatural deaths in Norway and Sweden - a study on victims of suicide and accidents compared with natural deaths in psychiatric patients.
    Gravensteen IK; Ekeberg Ø; Thiblin I; Helweg-Larsen K; Hem E; Rogde S; Tøllefsen IM
    BMC Psychiatry; 2019 Jan; 19(1):33. PubMed ID: 30658618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.
    Wohlfarth A; Scheidweiler KB; Pang S; Zhu M; Castaneto M; Kronstrand R; Huestis MA
    Drug Test Anal; 2016 Aug; 8(8):779-91. PubMed ID: 26331297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project.
    Bäckberg M; Beck O; Jönsson KH; Helander A
    Clin Toxicol (Phila); 2015; 53(7):609-17. PubMed ID: 26083809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Expanding World of Novel Psychoactive Substances: Opioids.
    Zawilska JB
    Front Psychiatry; 2017; 8():110. PubMed ID: 28713291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DARK Classics in Chemical Neuroscience: Bucinnazine.
    Resnik K; Brandão P; Alves EA
    ACS Chem Neurosci; 2021 Oct; 12(19):3527-3534. PubMed ID: 34528782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New synthetic opioids: Part of a new addiction landscape.
    Karila L; Marillier M; Chaumette B; Billieux J; Franchitto N; Benyamina A
    Neurosci Biobehav Rev; 2019 Nov; 106():133-140. PubMed ID: 30217656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Fentanyl Analogs and Synthetic Opioids in Real Hair Samples.
    Salomone A; Palamar JJ; Bigiarini R; Gerace E; Di Corcia D; Vincenti M
    J Anal Toxicol; 2019 May; 43(4):259-265. PubMed ID: 30462247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rewarding and reinforcing effects of 4-chloro-2,5-dimethoxyamphetamine and AH-7921 in rodents.
    Cha HJ; Jeon SY; Jang HJ; Shin J; Kim YH; Suh SK
    Neurosci Lett; 2018 May; 676():66-70. PubMed ID: 29626650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
    Tyrkkö E; Andersson M; Kronstrand R
    Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying cases of heroin toxicity where 6-acetylmorphine (6-AM) is not detected by toxicological analyses.
    Ellis AD; McGwin G; Davis GG; Dye DW
    Forensic Sci Med Pathol; 2016 Sep; 12(3):243-7. PubMed ID: 27114260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical Approaches in Fatal Intoxication Cases Involving New Synthetic Opioids.
    Gerace E; Salomone A; Vincenti M
    Curr Pharm Biotechnol; 2018; 19(2):113-123. PubMed ID: 29621965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Life (and death) in Pink: The dangerous rise of synthetic opioids in the new psychoactive substances panorama.
    Santacroce R; Bosio E; Ferrero F; Mignone M
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):225-226. PubMed ID: 29249554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interest in eight new psychoactive substances before and after scheduling.
    Ledberg A
    Drug Alcohol Depend; 2015 Jul; 152():73-8. PubMed ID: 25981311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.